Insuman Rapid Solostar (Insulin Human)

Insuman Rapid Solostar is a rapid‑acting insulin used to manage blood glucose in diabetes mellitus.

• Type 1 diabetes mellitus: provides rapid‑acting insulin to control post‑prandial glucose levels.
• Type 2 diabetes mellitus: adds rapid‑acting insulin when oral agents are insufficient to achieve glycaemic targets.
• Diabetic ketoacidosis: used as part of insulin therapy to reduce severe hyperglycaemia.

• Insulin human binds to insulin receptors on cell membranes, activating the receptor’s tyrosine kinase activity. This triggers intracellular signaling pathways that promote glucose uptake in muscle and adipose tissue, suppress hepatic glucose production, and facilitate glycogen synthesis, thereby lowering circulating blood glucose concentrations.

Common Side Effects

• Hypoglycaemia: low blood glucose levels, especially if meals are missed or dosing is excessive.
• Injection‑site reactions: redness, swelling, or itching at the injection site.
• Weight gain: increased adipose tissue due to improved glucose utilisation.
• Lipodystrophy: localized changes in fat tissue with repeated injections.
• Edema: mild fluid retention, often in the lower extremities.
• Headache: transient mild to moderate headache.

Serious or Rare Side Effects

• Severe hypoglycaemia: neurological impairment, seizures, or loss of consciousness.
• Anaphylactic reaction: urticaria, bronchospasm, or angio‑edema requiring emergency treatment.
• Hypokalemia: low serum potassium levels, potentially causing cardiac arrhythmias.
• Insulin antibody formation: may alter insulin efficacy and cause unpredictable glycaemic control.

Precautions should be taken when using Insuman Rapid Solostar to ensure safe and effective therapy.

• Dose adjustment: modify dose during fasting, illness, or changes in physical activity.
• Blood‑glucose monitoring: frequent self‑monitoring is essential to avoid hypoglycaemia.
• Renal or hepatic impairment: use with caution and consider reduced dosing.
• Pregnancy and lactation: safety not established; weigh benefits against potential risks.
• Hypersensitivity: discontinue if signs of allergic reaction appear.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Insuman Rapid Solostar may interact with other medicines, affecting glucose control.

Major Interactions (Avoid)

• Beta‑blockers: can mask hypoglycaemia symptoms.
• MAO inhibitors: may potentiate insulin’s glucose‑lowering effect.
• Thiazide diuretics: can increase blood glucose levels.
• Corticosteroids: may raise glucose, requiring higher insulin doses.
• Alcohol: can enhance hypoglycaemia risk.

Moderate Interactions (Monitor Closely)

• ACE inhibitors: may increase insulin sensitivity, necessitating dose review.
• Oral contraceptives: can affect glucose metabolism.
• Thyroid hormones: may alter insulin requirements.
• Statins: monitor for rare cases of altered glucose control.
• Antidepressants (SSRIs): may influence glycaemic variability.